Tarun D Singh1, Jennifer E Fugate1, Alejandro A Rabinstein2. 1. From the Department of Neurology, Mayo Clinic, Rochester, MN. 2. From the Department of Neurology, Mayo Clinic, Rochester, MN. rabinstein.alejandro@mayo.edu.
Abstract
OBJECTIVE: To describe and analyze etiologies, clinical presentations, therapeutic management, and outcomes of patients with acute encephalitis and identify outcome predictors. METHODS: We conducted a retrospective review of patients diagnosed with acute encephalitis at Mayo Clinic Rochester between January 2000 and December 2012. On the basis of the final diagnosis, the patients were categorized into 3 groups: viral encephalitis, autoimmune encephalitis, and encephalitis of unknown/other etiology. Multivariate logistic regression analysis was used to analyze factors associated with good (modified Rankin Scale scores of 0-2) or poor (scores of 3-6) outcome at hospital discharge. RESULTS: We identified 198 patients (100 [50.5%] men and 98 [49.5%] women) with a median age of 58 years (range 41.8-69). Etiologies included viral infection (n = 95, 48%), autoimmune (n = 44, 22%), and unknown/others (n = 59, 30%). Good outcome at discharge was achieved by 48 patients (50.5%) with viral encephalitis, 17 (40.5%) with autoimmune encephalitis, and 32 (54.2%) with unknown/other etiologies. Mortality rates were 8%, 12%, and 5% in each of the 3 categories, respectively. On multivariate regression analysis, the factors that were associated with poor outcome were age 65 years or older (p = 0.0307), immunocompromised state (p = 0.0153), coma (p = 0.0062), mechanical ventilation (p = 0.0124), and acute thrombocytopenia (p = 0.0329). CSF polymorphonuclear cell count was also strongly associated with poor outcome in viral encephalitis (p = 0.0027). CONCLUSIONS: Advanced age, immunocompromised state, coma, mechanical ventilation, and acute thrombocytopenia portend a worse prognosis in acute encephalitis. In contrast, the etiology of encephalitis, development of seizures or focal neurologic deficit, and MRI findings were not associated with clinical outcomes.
OBJECTIVE: To describe and analyze etiologies, clinical presentations, therapeutic management, and outcomes of patients with acute encephalitis and identify outcome predictors. METHODS: We conducted a retrospective review of patients diagnosed with acute encephalitis at Mayo Clinic Rochester between January 2000 and December 2012. On the basis of the final diagnosis, the patients were categorized into 3 groups: viral encephalitis, autoimmune encephalitis, and encephalitis of unknown/other etiology. Multivariate logistic regression analysis was used to analyze factors associated with good (modified Rankin Scale scores of 0-2) or poor (scores of 3-6) outcome at hospital discharge. RESULTS: We identified 198 patients (100 [50.5%] men and 98 [49.5%] women) with a median age of 58 years (range 41.8-69). Etiologies included viral infection (n = 95, 48%), autoimmune (n = 44, 22%), and unknown/others (n = 59, 30%). Good outcome at discharge was achieved by 48 patients (50.5%) with viral encephalitis, 17 (40.5%) with autoimmune encephalitis, and 32 (54.2%) with unknown/other etiologies. Mortality rates were 8%, 12%, and 5% in each of the 3 categories, respectively. On multivariate regression analysis, the factors that were associated with poor outcome were age 65 years or older (p = 0.0307), immunocompromised state (p = 0.0153), coma (p = 0.0062), mechanical ventilation (p = 0.0124), and acute thrombocytopenia (p = 0.0329). CSF polymorphonuclear cell count was also strongly associated with poor outcome in viral encephalitis (p = 0.0027). CONCLUSIONS: Advanced age, immunocompromised state, coma, mechanical ventilation, and acute thrombocytopenia portend a worse prognosis in acute encephalitis. In contrast, the etiology of encephalitis, development of seizures or focal neurologic deficit, and MRI findings were not associated with clinical outcomes.
Authors: Alexander Filatenkov; Timothy E Richardson; Elena Daoud; Sarah F Johnson-Welch; Denise M Ramirez; Jose Torrealba; Benjamin Greenberg; Nancy L Monson; Veena Rajaram Journal: Neuroreport Date: 2017-09-27 Impact factor: 1.837
Authors: C López-Sánchez; E Sulleiro; C Bocanegra; S Romero; G Codina; I Sanz; J Esperalba; J Serra; C Pigrau; J Burgos; B Almirante; V Falcó Journal: Eur J Clin Microbiol Infect Dis Date: 2016-11-25 Impact factor: 3.267
Authors: Nicolas Gaspard; Brandon P Foreman; Vincent Alvarez; Christian Cabrera Kang; John C Probasco; Amy C Jongeling; Emma Meyers; Alyssa Espinera; Kevin F Haas; Sarah E Schmitt; Elizabeth E Gerard; Teneille Gofton; Peter W Kaplan; Jong W Lee; Benjamin Legros; Jerzy P Szaflarski; Brandon M Westover; Suzette M LaRoche; Lawrence J Hirsch Journal: Neurology Date: 2015-08-21 Impact factor: 9.910
Authors: Kyle G Rodino; Michel Toledano; Andrew P Norgan; Bobbi S Pritt; Matthew J Binnicker; Joseph D Yao; Allen J Aksamit; Robin Patel Journal: J Clin Microbiol Date: 2020-11-18 Impact factor: 5.948
Authors: Tarun D Singh; Jennifer E Fugate; Sara Hocker; Eelco F M Wijdicks; Allen J Aksamit; Alejandro A Rabinstein Journal: J Neurol Date: 2015-11-14 Impact factor: 4.849
Authors: Tanuwong Viarasilpa; Nicha Panyavachiraporn; Gamaleldin Osman; Christopher Parres; Panayiotis Varelas; Meredith Van Harn; Stephan A Mayer Journal: Neurocrit Care Date: 2019-02 Impact factor: 3.210